Last filing: Aug 19, 2026. Most recent sale before this period: Jan 27, 2025.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Jan 27, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Bio-Techne (TECH) | Chief Executive Officer, Director | May 3, 2018 | Aug 19, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 15, 2026, Bio-Techne: 21,470 shares vested; 10,821 shares withheld by the company for taxes. 1 filing: 1
- Jul 28, 2026, Bio-Techne: 35,000 shares acquired by exercising options; 28,686 shares withheld by the company for taxes. 1 filing: 1
- May 5, 2026, Bio-Techne: 26,692 shares acquired by exercising options; 23,951 shares withheld by the company for taxes. 1 filing: 1
- Apr 22, 2026, Bio-Techne: 11,344 shares acquired by exercising options; 1,363 shares withheld by the company for taxes. 1 filing: 1
- Apr 14, 2026, Bio-Techne: 36,500 shares acquired by exercising options; 32,088 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.